419
1. Ahrens B, Schulz G, Bellach J, Niggemann B, Beyer K. Chemokine levels in serum of children with atopic dermatitis with regard to severity and sensitization status. Pediatr Allergy Immunol. 2015 Nov;26(7):634-40. doi: 10.1111/pai.12431. Epub 2015 Jul 14. PMID: 26102348.
2. Basu K, Palmer CN, Lipworth BJ, McLean WH, Terron-Kwiatkowski A, Zhao Y, Liao H, Smith FJ, Mitra A, Mukhopadhyay S. Filaggrin null mutations are associated with increased asthma exacerbations in children and young adults. Allergy. 2008 Sep;63(9):1211-7. doi: 10.1111/j.1398-9995.2008.01660.x. Epub 2008 Feb 25. PMID: 18307574.
3. Bieber T, D'Erme AM, Akdis CA, Traidl-Hoffmann C, Lauener R, Schäppi G, Schmid-Grendelmeier P. Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go? J Allergy Clin Immunol. 2017 Apr;139(4S):S58-S64. doi: 10.1016/j.jaci.2017.01.008. PMID: 28390478.
4. Blauvelt A, de Bruin-Weller M, Gooderham M, Cather JC, Weisman J, Pariser D, Simpson EL, Papp KA, Hong HC, Rubel D, Foley P, Prens E, Griffiths CEM, Etoh T, Pinto PH, Pujol RM, Szepietowski JC, Ettler K, Kemény L, Zhu X, Akinlade B, Hultsch T, Mastey V, Gadkari A, Eckert L, Amin N, Graham NMH, Pirozzi G, Stahl N, Yancopoulos GD, Shumel B. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet. 2017 Jun 10;389(10086):2287-2303. doi: 10.1016/S0140-6736(17)31191-1. Epub 2017 May 4. PMID: 28478972.
5. Brunner PM, Pavel AB, Khattri S, Leonard A, Malik K, Rose S, Jim On S, Vekaria AS, Traidl-Hoffmann C, Singer GK, Baum D, Gilleaudeau P, Sullivan-Whalen M, Fuentes-Duculan J, Li X, Zheng X, Estrada Y, Garcet S, Wen HC, Gonzalez J, Coats I, Cueto I, Neumann AU, Lebwohl MG, Krueger JG, GuttmanYassky E. Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab. J Allergy Clin Immunol. 2019 Jan;143(1):142-154. doi: 10.1016/j.jaci.2018.07.028. Epub 2018 Aug 17. PMID: 30121291.
6. Chovatiya R, Silverberg JI. The Heterogeneity of Atopic Dermatitis. J Drugs Dermatol. 2022 Feb 1;21(2):172-176. doi: 10.36849/JDD.6408. PMID: 35133102; PMCID: PMC10119386.
7. Czarnowicki T, Esaki H, Gonzalez J, Malajian D, Shemer A, Noda S, Talasila S, Berry A, Gray J, Becker L, Estrada Y, Xu H, Zheng X, Suárez-Fariñas M, Krueger JG, Paller AS, Guttman-Yassky E. Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA (+) TH22/TC22 cell subsets. J Allergy Clin Immunol. 2015 Oct;136(4): 941951.e3. doi: 10.1016/j.jaci.2015.05.049. Epub 2015 Aug 1. PMID: 26242300; PMCID: PMC4946641.
8. David Boothe W, Tarbox JA, Tarbox MB. Atopic Dermatitis: Pathophysiology. Adv Exp Med Biol. 2017; 1027:21-37. doi: 10.1007/978-3-319-64804-0_3. PMID: 29063428.
9. Domínguez-Hüttinger E, Christodoulides P, Miyauchi K, Irvine AD, Okada-Hatakeyama M, Kubo M, Tanaka RJ. Mathematical modeling of atopic dermatitis reveals "double-switch" mechanisms underlying 4 common disease phenotypes. J Allergy Clin Immunol. 2017 Jun;139(6):1861-1872.e7. doi: 10.1016/j.jaci.2016.10.026. Epub 2016 Dec 5. PMID: 27931974.
10. Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, Berger TG, Bergman JN, Cohen DE Cooper KD, Cordoro KM, Davis DM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Silverman RA, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Sidbury R. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014 Feb;70(2):338-51. doi: 10.1016/j.jaad.2013.10.010. Epub 2013 Nov 27. PMID: 24290431; PMCID: PMC4410183.
11. Emson C, Pham TH, Manetz S, Newbold P. Periostin and Dipeptidyl Peptidase-4: Potential Biomarkers of Interleukin 13 Pathway Activation in Asthma and Allergy. Immunol Allergy Clin North Am. 2018 Nov;38(4):611-628. doi: 10.1016/j.iac.2018.06.004. Epub 2018 Sep 18. PMID: 30342583.
12. Esaki H, Brunner PM, Renert-Yuval Y, Czarnowicki T, Huynh T, Tran G, Lyon S, Rodriguez G, Immaneni S, Johnson DB, Bauer B, Fuentes-Duculan J, Zheng X, Peng X, Estrada YD, Xu H, de Guzman Strong C, Suárez-Fariñas M, Krueger JG, Paller AS, Guttman-Yassky E. Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin. J Allergy Clin Immunol. 2016 Dec;138(6):1639-1651. doi: 10.1016/j.jaci.2016.07.013. Epub 2016 Sep 23. PMID: 27671162.
13. Fujisawa T, Nagao M, Hiraguchi Y, Katsumata H, Nishimori H, Iguchi K, Kato Y, Higashiura M, Ogawauchi I, Tamaki K. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis. Pediatr Allergy Immunol. 2009 Nov;20(7):633-41. doi: 10.1111/j.1399-3038.2009.00851.x. Epub 2009 Feb 11. PMID: 19236603.
14. Garzorz-Stark N, Krause L, Lauffer F, Atenhan A, Thomas J, Stark SP, Franz R, Weidinger S, Balato A, Mueller NS, Theis FJ, Ring J, Schmidt-Weber CB, Biedermann T, Eyerich S, Eyerich K. A novel molecular disease classifier for psoriasis and eczema. Exp Dermatol. 2016 Oct;25(10):767-74. doi: 10.1111/exd.13077. PMID: 27193975.
15. Glickman JW, Han J, Garcet S, Krueger JG, Pavel AB, Guttman-Yassky E. Improving evaluation of drugs in atopic dermatitis by combining clinical and molecular measures. J Allergy Clin Immunol Pract. Nov-Dec;8(10):3622-3625.e19. doi: 10.1016/j.jaip.2020.07.015. Epub 2020 Jul 20. PMID: 32702518.
16. Gromova M, Vaggelas A, Dallmann G, Seimetz D. Biomarkers: Opportunities and Challenges for Drug Development in the Current Regulatory Landscape. Biomark Insights. 2020 Dec 8; 15:1177271920974652. doi: 10.1177/1177271920974652. PMID: 33343195; PMCID: PMC7727038.
17. He H, Del Duca E, Diaz A, Kim HJ, Gay-Mimbrera J, Zhang N, Wu J, Beaziz J, Estrada Y, Krueger JG, Pavel AB, Ruano J, Guttman-Yassky E. Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities. J Allergy Clin Immunol. 2021 Apr;147(4):1369-1380. doi: 10.1016/j.jaci.2020.08.041. Epub 2020 Oct 1. PMID: 33011244.
18. Horimukai K, Morita K, Narita M, Kondo M, Kabashima S, Inoue E, Sasaki T, Niizeki H, Saito H, Matsumoto K, Ohya Y. Transepidermal water loss measurement during infancy can predict the subsequent development of atopic dermatitis regardless of filaggrin mutations. Allergol Int. 2016 Jan;65(1):103-8. doi: 10.1016/j.alit.2015.09.004. Epub 2015 Oct 29. PMID: 26666481.
19. Hulshof L, Overbeek SA, Wyllie AL, Chu MLJN, Bogaert D, de Jager W, Knippels LMJ, Sanders EAM, van Aalderen WMC, Garssen J, Van't Land B, Sprikkelman AB; Clinical Study Group. Exploring Immune Development in Infants With Moderate to Severe Atopic Dermatitis. Front Immunol. 2018 Mar 29; 9:630. doi: 10.3389/fimmu.2018.00630. PMID: 29966024; PMCID: PMC5884950.
20. Imai T, Yoshida T, Baba M, Nishimura M, Kakizaki M, Yoshie O. Molecular cloning of a novel T celldirected CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem. 1996 Aug 30;271(35):21514-21. doi: 10.1074/jbc.271.35.21514. PMID: 8702936.
21. Kage P, Zarnowski J, Simon JC, Treudler R. Atopic dermatitis and psychosocial comorbidities - What's new? Allergol Select. 2020 Nov 6; 4:86-96. doi: 10.5414/ALX02174E. PMID: 33195970; PMCID: PMC7659463.
22. Kataoka Y. Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis. J Dermatol. 2014 Mar;41(3):221-9. doi: 10.1111/1346-8138.12440. PMID: 24628072.
23. Kezic S, O'Regan GM, Lutter R, Jakasa I, Koster ES, Saunders S, Caspers P, Kemperman PM, Puppels GJ, Sandilands A, Chen H, Campbell LE, Kroboth K, Watson R, Fallon PG, McLean WH, Irvine AD. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. J Allergy Clin Immunol. 2012 Apr;129(4):1031-9.e1. doi: 10.1016/j.jaci.2011.12.989. Epub 2012 Feb 8. PMID: 22322004; PMCID: PMC3627959.
24. Kim J, Kim BE, Lee J, Han Y, Jun HY, Kim H, Choi J, Leung DYM, Ahn K. Epidermal thymic stromal lymphopoietin predicts the development of atopic dermatitis during infancy. J Allergy Clin Immunol. 2016 Apr;137(4):1282-1285.e4. doi: 10.1016/j.jaci.2015.12.1306. Epub 2016 Feb 12. PMID: 26879860.
25. Kou K, Okawa T, Yamaguchi Y, Ono J, Inoue Y, Kohno M, Matsukura S, Kambara T, Ohta S, Izuhara K, Aihara M. Periostin levels correlate with disease severity and chronicity in patients with atopic dermatitis. Br J Dermatol. 2014 Aug;171(2):283-91. doi: 10.1111/bjd.12943. Epub 2014 Aug 5. PMID: 24601864.
26. Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020 Aug 1;396(10247):345-360. doi: 10.1016/S0140-6736(20)31286-1. Erratum in: Lancet. 2020 Sep 12;396(10253):758. doi: 10.1016/S0140-6736(20)31825-0. PMID: 32738956.
27. Lauffer F, Baghin V, Standl M, Stark SP, Jargosch M, Wehrle J, Thomas J, Schmidt-Weber CB, Biedermann T, Eyerich S, Eyerich K, Garzorz-Stark N. Predicting persistence of atopic dermatitis in children using clinical attributes and serum proteins. Allergy. 2021 Apr;76(4):1158-1172. doi: 10.1111/all.14557. Epub 2020 Sep 1. PMID: 32794228.
28. Mastraftsi S, Vrioni G, Bakakis M, Nicolaidou E, Rigopoulos D, Stratigos A J, & Gregoriou S. Atopic dermatitis: striving for reliable biomarkers. Journal of Clinical Medicine. Aug 9;11(16):4639. doi: 10.3390/jcm11164639
29. Miyahara H, Okazaki N, Nagakura T, Korematsu S, Izumi T. Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy. Clin Exp Allergy. 2011 Feb;41(2):186-91. doi: 10.1111/j.1365-2222.2010.03634.x. Epub 2010 Nov 5. PMID: 21054588.
30. Ní Chaoimh C, Nico C, Puppels GJ, Caspers PJ, Wong XFCC, Common JE, Irvine AD, Hourihane JO. In vivo Raman spectroscopy discriminates between FLG loss-of-function carriers vs wild-type in day 1-4 neonates. Ann Allerg Asthm Immunol. 2020 May;124(5):500-504. doi:10.1016/j.anai.2020.01.022. Epub 2020 Feb 6. PMID: 32035937.
31. Ní Chaoimh C, Nico C, Puppels GJ, Caspers PJ, Wong XFCC, Common JE, Irvine AD, Hourihane JO. In vivo Raman spectroscopy discriminates between FLG loss-of-function carriers vs wild-type in day 1-4 neonates. Ann AllergyAsthma Immunol. 2020 May;124(5):500-504. doi:10.1016/j.anai.2020.01.022. Epub 2020 Feb 6. PMID: 32035937.
32. Nomura T, Wu J, Kabashima K, Guttman-Yassky E. Endophenotypic Variations of Atopic Dermatitis by Age, Race, and Ethnicity. J Allergy Clin Immunol Pract. 2020 Jun;8(6):1840-1852. doi: 10.1016/j.jaip.2020.02.022. PMID: 32499033.
33. Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66 Suppl 1:8-16. doi: 10.1159/000370220. Epub 2015 Apr 24. PMID: 25925336.
34. Olesen AB, Andersen G, Jeppesen DL, Benn CS, Juul S, Thestrup-Pedersen K. Thymus is enlarged in children with current atopic dermatitis. A cross-sectional study. Acta Derm Venereol. 2005;85(3):240-3. doi: 10.1080/00015550510026352. PMID: 16040410.
35. Ozceker D, Bulut M, Ozbay AC, Dilek F, Koser M, Tamay Z, Guler N. Assessment of IL-31 levels and disease severity in children with atopic dermatitis. Allergol Immunopathol (Madr). 2018 JulAug;46(4):322-325. doi: 10.1016/j.aller.2017.10.005. Epub 2018 Mar 17. PMID: 29555105.
36. Patel N, Feldman SR. Adherence in Atopic Dermatitis. Adv Exp Med Biol. 2017; 1027:139-159. doi: 10.1007/978-3-319-64804-0_12. PMID: 29063437.
37. Paternoster L., Standl M., Waage J., Baurecht H., Hotze M., Strachan D.P., Curtin J.A., Bønnelykke K., Tian C., Takahashi A., et al. Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat. Genet. 2015;47:1449–1456. doi: 10.1038/ng.3424.
38. Piper E, Brightling C, Niven R, Oh C, Faggioni R, Poon K, She D, Kell C, May RD, Geba GP, Molfino NA. A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma. Eur Respir J. 2013 Feb;41(2):330-8. doi: 10.1183/09031936.00223411. Epub 2012 Jun 27. PMID: 22743678; PMCID: PMC3561510.
39. Quaranta M, Knapp B, Garzorz N, Mattii M, Pullabhatla V, Pennino D, Andres C, Traidl-Hoffmann C, Cavani A, Theis FJ, Ring J, Schmidt-Weber CB, Eyerich S, Eyerich K. Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema. Sci Transl Med. 2014 Jul 9;6(244):244ra90. doi: 10.1126/scitranslmed.3008946. PMID: 25009230.
40. Renert-Yuval Y, Thyssen JP, Bissonnette R, Bieber T, Kabashima K, Hijnen D, Guttman-Yassky E. Biomarkers in atopic dermatitis-a review on behalf of the International Eczema Council. J Allergy Clin Immunol. 2021 Apr;147(4):1174-1190.e1. doi: 10.1016/j.jaci.2021.01.013. Epub 2021 Jan 28. PMID: 33516871; PMCID: PMC11304440.
41. Roekevisch E, Szegedi K, Hack DP, Schram ME, Res PCJM, Bos JD, Leeflang MMG, Luiten RM, Kezic S, Spuls PI, Middelkamp-Hup MA. Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients. J Eur Acad Dermatol Venereol. 2020 Jul;34(7):1545-1554. doi: 10.1111/jdv.16164. Epub 2020 Feb 5. PMID: 31855303; PMCID: PMC7496710.
42. Siegels D, Haufe E, Heinrich L, Werfel T, Weidinger S, Schmitt J; TREATgermany Study Group. Status report on the atopic dermatitis registry TREATgermany. Allergol Select. 2021 Aug 27; 5:274-286. doi: 10.5414/ALX02262E. PMID: 34532636; PMCID: PMC8439109.
43. Silverberg JI, Barbarot S, Gadkari A, Simpson EL, Weidinger S, Mina-Osorio P, Rossi AB, Brignoli L, Saba G, Guillemin I, Fenton MC, Auziere S, Eckert L. Atopic dermatitis in the pediatric population: A cross-sectional, international epidemiologic study. Ann Allergy Asthma Immunol. 2021 Apr;126(4):417-428.e2. doi: 10.1016/j.anai.2020.12.020. Epub 2021 Jan 6. PMID: 33421555.
44. Silverberg NB, Silverberg JI. Inside out or outside in: does atopic dermatitis disrupt barrier function or does disruption of barrier function trigger atopic dermatitis? Cutis. 2015 Dec;96(6):359-61. PMID: 26761930.
45. Simpson EL, Chalmers JR, Hanifin JM, Thomas KS, Cork MJ, McLean WH, Brown SJ, Chen Z, Chen Y, Williams HC. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014 Oct;134(4):818-23. doi: 10.1016/j.jaci.2014.08.005. PMID: 25282563; PMCID: PMC4180007.
46. Simpson EL, Villarreal M, Jepson B, Rafaels N, David G, Hanifin J, Taylor P, Boguniewicz M, Yoshida T, De Benedetto A, Barnes KC, Leung DYM, Beck LA. Patients with Atopic Dermatitis Colonized with Staphylococcus aureus Have a Distinct Phenotype and Endotype. J Invest Dermatol. 2018 Oct;138(10):2224-2233. doi: 10.1016/j.jid.2018.03.1517. Epub 2018 Mar 28. PMID: 29604251; PMCID: PMC6153055.
47. Song TW, Sohn MH, Kim ES, Kim KW, Kim KE. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis. Clin Exp Allergy. 2006 Mar;36(3):346-51. doi: 10.1111/j.1365-2222.2006.02430.x. PMID: 16499646.
48. South AP, Cabral A, Ives JH, James CH, Mirza G, Marenholz I, Mischke D, Backendorf C, Ragoussis J, Nizetic D. Human epidermal differentiation complex in a single 2.5 Mbp long continuum of overlapping DNA cloned in bacteria integrating physical and transcript maps. J Invest Dermatol. 1999 Jun;112(6):910-8. doi: 10.1046/j.1523-1747.1999.00613.x. PMID: 10383738.
49. Srour J, Berg E, Mahltig B, Smolik T, Wollenberg A. Evaluation of antimicrobial textiles for atopic dermatitis. J Eur Acad Dermatol Venereol. 2019 Feb;33(2):384-390. doi: 10.1111/jdv.15123. Epub 2018 Jul 12. PMID: 29894014.
50. Staudacher A, Hinz T, Novak N, von Bubnoff D, Bieber T. Exaggerated IDO1 expression and activity in Langerhans cells from patients with atopic dermatitis upon viral stimulation: a potential predictive biomarker for high risk of Eczema herpeticum. Allergy. 2015 Nov;70(11):1432-9. doi: 10.1111/all.12699. Epub 2015 Sep 2. PMID: 26198597; PMCID: PMC4609278.
51. Thijs J, Krastev T, Weidinger S, Buckens CF, de Bruin-Weller M, Bruijnzeel-Koomen C, Flohr C, Hijnen D. Biomarkers for atopic dermatitis: a systematic review and meta-analysis. Curr Opin Allergy Clin Immunol. 2015 Oct;15(5):453-60. doi: 10.1097/ACI.0000000000000198. PMID: 26226355.
52. Thijs JL, de Bruin-Weller MS, Hijnen D. Current and Future Biomarkers in Atopic Dermatitis. Immunol Allergy Clin North Am. 2017 Feb;37(1):51-61. doi: 10.1016/j.iac.2016.08.008. Epub 2016 Oct 28. PMID: 27886910.
53. Thijs JL, Knipping K, Bruijnzeel-Koomen CA, Garssen J, de Bruin-Weller MS, Hijnen DJ. Immunoglobulin free light chains in adult atopic dermatitis patients do not correlate with disease severity. Clin Transl Allergy. 2016 Dec 6; 6:44. doi: 10.1186/s13601-016-0132-9. PMID: 27980722; PMCID: PMC5139123.
54. Tokura Y, Hayano S. Subtypes of atopic dermatitis: From phenotype to endotype. Allergol Int. 2022 Jan;71(1):14-24. doi: 10.1016/j.alit.2021.07.003. Epub 2021 Jul 31. PMID: 34344611.
55. Torres T, Ferreira EO, Gonçalo M, Mendes-Bastos P, Selores M, Filipe P. Update on Atopic Dermatitis. Acta Med Port. 2019 Sep 2;32(9):606-613. doi: 10.20344/amp.11963. Epub 2019 Sep 2. PMID: 31493365.
56. Ungar B, Garcet S, Gonzalez J, Dhingra N, Correa da Rosa J, Shemer A, Krueger JG, Suarez-Farinas M, Guttman-Yassky E. An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease. J Invest Dermatol. 2017 Mar;137(3):603-613. doi: 10.1016/j.jid.2016.09.037. Epub 2016 Nov 4. PMID: 27825969.
57. Vestergaard C, Bang K, Gesser B, Yoneyama H, Matsushima K, Larsen CG. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol. 2000 Oct;115(4):640-6. doi: 10.1046/j.1523-1747.2000.00115.x. PMID: 10998136.
58. Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nat Rev Dis Primers. 2018 Jun 21;4(1):1. doi: 10.1038/s41572-018-0001-z. PMID: 29930242.
59. Weidinger S, O'Sullivan M, Illig T, Baurecht H, Depner M, Rodriguez E, Ruether A, Klopp N, Vogelberg C, Weiland SK, McLean WH, von Mutius E, Irvine AD, Kabesch M. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol. 2008 May;121(5):1203-1209.e1. doi: 10.1016/j.jaci.2008.02.014. Epub 2008 Apr 8. PMID: 18396323.
60. Werfel T, Allam JP, Biedermann T, Eyerich K, Gilles S, Guttman-Yassky E, Hoetzenecker W, Knol E, Simon HU, Wollenberg A, Bieber T, Lauener R, Schmid-Grendelmeier P, Traidl-Hoffmann C, Akdis CA. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol. 2016 Aug;138(2):336-49. doi: 10.1016/j.jaci.2016.06.010. PMID: 27497276.
61. Wollenberg A, Howell MD, Guttman-Yassky E, Silverberg JI, Kell C, Ranade K, Moate R, van der Merwe R. Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb. J Allergy Clin Immunol. Jan;143(1):135-141. doi: 10.1016/j.jaci.2018.05.029. Epub 2018 Jun 12. PMID: 29906525.
62. Wollenberg A, Werfel T, Ring J, Ott H, Gieler U, Weidinger S. Atopic Dermatitis in Children and Adults—Diagnosis and Treatment. Dtsch Arztebl Int. 2023 Mar 31;120(13):224-234. doi: 10.3238/arztebl.m2023.0011. PMID: 36747484; PMCID: PMC10277810.
63. Yasukochi Y, Nakahara T, Abe T, Kido-Nakahara M, Kohda F, Takeuchi S, Hagihara A, Furue M. Reduction of serum TARC levels in atopic dermatitis by topical anti-inflammatory treatments. Asian Pac J Allergy Immunol. 2014 Sep;32(3):240-5. doi: 10.12932/AP0419.32.3.2014. PMID: 25268342.
64. Zheng X, Nakamura K, Furukawa H, Nishibu A, Takahashi M, Tojo M, Kaneko F, Kakinuma T, Tamaki K. Demonstration of TARC and CCR4 mRNA expression and distribution using in situ RT-PCR in the lesional skin of atopic dermatitis. J Dermatol. 2003 Jan;30(1):26-32. doi: 10.1111/j.13468138.2003.tb00329.x. PMID: 12598706.
65. Ziegler, S. F. Thymic stromal lymphopoietin, skin barrier dysfunction, and the atopic march. Annals of Allergy, Asthma & Immunology. 2021, 127(3), 306-311.
66. Ziehfreund S, Tizek L, Hangel N, Fritzsche MC, Weidinger S, Smith C, Bryce PJ, Greco D, van den Bogaard EH, Flohr C, Rastrick Ucb J, Eyerich S, Buyx A, Conrad C, Eyerich K, Zink A. Requirements and expectations of high-quality biomarkers for atopic dermatitis and psoriasis in 2021-a two-round Delphi survey among international experts. J Eur Acad Dermatol Venereol. 2022 Sep;36(9):1467-1476. doi: 10.1111/jdv.18178. Epub 2022 May 17. PMID: 35470457.